Inveresk Merger
Strategic, customer-driven transaction supported by market opportunity
Demand driven by pharma and biotech outsourcing
Broadened CRL’s portfolio of high-end products and services
- General toxicology
- Specialty infusion and inhalation toxicology
- Clinical services